Individual Investors

Subscribe to email updates

Subscribe now

Financial Professionals

Subscribe to email updates, or password protected financial professional-only content
email address/username
password

PPH VanEck Vectors Pharmaceutical ETF

  • Fund Description

    VanEck Vectors Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

  •  
      

    • Fund Ticker

      PPH
    • Exchange

      NASDAQ
    • Commencement

      12/20/2011
    • ETF Structure

      Physical
    • Administrator

      Van Eck Associates
    • Custodian

      Bank of New York Mellon
    • Index Ticker

      MVPPHTR
    • Index Rebalancing

      Quarterly
  •  
    as of 09/23/16

    • 30-Day SEC Yield1

      1.80%
    • Total Net Assets

      $242.8M
    • Number of Holdings

      26
    • Options

      Available
    • Gross Expense Ratio2

      0.41%
    • Net Expense Ratio/TER2

      0.36%
    • Distribution Frequency

      Quarterly
    • Next Distribution Date

      09/30/2016
  • Portfolio Composition (%)
    as of 09/23/16

    • % of Net Assets
    • Stocks

      99.82
    • Bonds

      0.00
    • Other

      0.00
    • Cash

      0.18
  • Download All HoldingsDaily Holdings (%) as of 09/23/16

    Total Holdings: 26
    Holding Name
    Ticker
    SharesMarket Value
    (US$)
    % of Net
    Assets
    Astrazeneca Plc
    AZN US
    365,061
    12,401,1225.11
    Novartis Ag
    NVS US
    150,731
    12,281,5625.06
    Merck & Co Inc
    MRK US
    192,663
    12,130,0625.00
    Abbvie Inc
    ABBV US
    186,436
    12,114,6114.99
    Bristol-Myers Squibb Co
    BMY US
    214,119
    12,093,4414.98
    Johnson & Johnson
    JNJ US
    101,268
    12,031,6514.95
    Glaxosmithkline Plc
    GSK US
    276,420
    12,002,1564.94
    Pfizer Inc
    PFE US
    347,667
    11,911,0714.91
    Novo Nordisk A/S
    NVO US
    263,951
    11,846,1214.88
    Sanofi
    SNY US
    305,877
    11,730,3834.83
    Shire Plc
    SHPG US
    56,309
    11,433,5424.71
    Mylan Nv
    MYL US
    270,440
    11,374,7064.68
    Eli Lilly & Co
    LLY US
    138,713
    11,257,9474.64
    Perrigo Co Plc
    PRGO US
    113,354
    11,040,6804.55
    Abbott Laboratories
    ABT US
    260,178
    10,976,9104.52
    Teva Pharmaceutical Industries Ltd
    TEVA US
    212,545
    10,939,6914.51
    Zoetis Inc
    ZTS US
    209,482
    10,790,4184.44
    Amerisourcebergen Corp
    ABC US
    124,233
    10,352,3364.26
    Mckesson Corp
    MCK US
    58,939
    9,847,5284.06
    Valeant Pharmaceuticals International I
    VRX US
    283,257
    7,851,8843.23
    Mallinckrodt Plc
    MNK US
    61,018
    4,656,2841.92
    Jazz Pharmaceuticals Plc
    JAZZ US
    32,517
    4,135,8371.70
    Gw Pharmaceuticals Plc
    GWPH US
    24,563
    2,641,9961.09
    Endo International Plc
    ENDP US
    110,965
    2,595,4711.07
    Akorn Inc
    AKRX US
    66,471
    1,942,2830.80
    Other/Cash
    --
    --
    443,6980.18
    These are not recommendations to buy or to sell any security. Securities and holdings may vary.